Root Financial Partners’s Amplify Weight Loss Drug & Treatment ETF THNR Stock Holding History
Bought
Maintained
Sold
Other funds holding THNR
Root Financial Partners's THNR Position: Q3 2026 in Review
Root Financial Partners opened a new position in Amplify Weight Loss Drug & Treatment ETF (THNR) in Q3 2026: 74 shares worth $1.86K. The stake represents ﹤0.01% of the portfolio and ranks #2682 among its holdings.
6 funds tracked by Wall St. Rank hold THNR as of Q3 2026.
- Root Financial Partners held 74 shares of Amplify Weight Loss Drug & Treatment ETF worth $1.86K as of Q3 2026.
- Amplify Weight Loss Drug & Treatment ETF was a new Root Financial Partners position in Q3 2026.
- Amplify Weight Loss Drug & Treatment ETF made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2682 holding.
- 6 funds tracked by Wall St. Rank held Amplify Weight Loss Drug & Treatment ETF as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.